Clinical Trial Update: A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial update reports results for guselkumab in adults with moderately to severely active ulcerative colitis, sponsored by Janssen Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Ulcerative Colitis | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-11-18